KIF1A

From WikiMD's WELLNESSPEDIA

KIF1A is a gene that encodes the protein kinesin family member 1A. This protein is a member of the kinesin family, which is involved in the transport of organelles and vesicles within cells. Mutations in the KIF1A gene have been associated with several neurological disorders, including hereditary spastic paraplegia, neuropathy, and mental retardation.

Structure[edit]

The KIF1A gene is located on the short (p) arm of chromosome 2 at position 23.1. The protein encoded by this gene is a member of the kinesin family, which is characterized by a highly conserved motor domain. This domain is responsible for the protein's ability to bind to microtubules and use the energy from ATP hydrolysis to move along these structures.

Function[edit]

The KIF1A protein is involved in the transport of organelles and vesicles within cells. It is particularly important for the transport of synaptic vesicles in neurons. These vesicles contain neurotransmitters, which are chemicals that transmit signals from one neuron to another. By transporting these vesicles, the KIF1A protein plays a crucial role in neuronal communication.

Clinical significance[edit]

Mutations in the KIF1A gene have been associated with several neurological disorders. These include hereditary spastic paraplegia, a condition characterized by weakness and stiffness in the leg muscles; neuropathy, a condition that affects the peripheral nerves; and mental retardation. In many cases, these conditions are inherited in an autosomal dominant manner, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

Research[edit]

Research into the KIF1A gene and its associated disorders is ongoing. Scientists are particularly interested in understanding how mutations in this gene lead to neurological disorders, and in developing potential treatments for these conditions.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.